Finance

Lists
ACXP:NASDAQ
Acurx Pharmaceuticals Inc
1,03 $
+0,98%
(+0,0100) 1D
1,13 $
+9,71% (+0,10)
After hours
Closed: 4 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACXP...
Open
1,07 $
High
1,08 $
Low
1,02 $
Mkt. cap
5,73 մլն
Avg. vol.
82,22 հզր
Volume
0,00
52-wk high
7,54 $
52-wk low
1,01 $
EPS
-3,10 $
Beta
-2,08
Shares outstanding
5,56 մլն
No. of employees
4
Open
1,07 $
High
1,08 $
Low
1,02 $
Mkt. cap
5,73 մլն
Avg. vol.
82,22 հզր
Volume
0,00
52-wk high
7,54 $
52-wk low
1,01 $
EPS
-3,10 $
Beta
-2,08
Shares outstanding
5,56 մլն
No. of employees
4
News stories
From web sources and news partners
About Acurx Pharmaceuticals Inc
CEODavid P Luci
Employees4
Founded2017
Headquarters-
Sector-
Industry-
Analyst ratings
Based on 3 analysts giving stock ratings to ACXP in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ACXP in the last 3 months.
Highest
Current 1,03 $
31,00 $ (+2 909,71%)
Average
17,00 $ (+1 550,49%)
Lowest
10,00 $ (+870,87%)
Analyst
Recommendation
Action
Price target
Projected
Date
James Molloy
Alliance Global Partners
Buy
Reiterated
10,00 $
+870,9%
09/29/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
31,00 $
+2 909,7%
09/29/2026
Jason McCarthy
Maxim Group
Buy
Maintained
10,00 $
+870,9%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
429,69 հզր
281,81 հզր
341,47 հզր
1,07 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,60 մլն
1,34 մլն
1,37 մլն
1,24 մլն
Operating expense
2,03 մլն
1,62 մլն
1,72 մլն
2,31 մլն
Total operating expenses
2,03 մլն
1,62 մլն
1,72 մլն
2,31 մլն
Operating income
-2,03 մլն
-1,62 մլն
-1,72 մլն
-2,31 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-1,99 մլն
-1,58 մլն
-1,68 մլն
-2,25 մլն
EBT excluding unusual items
-1,99 մլն
-1,58 մլն
-1,68 մլն
-2,25 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,99 մլն
-1,58 մլն
-1,68 մլն
-2,25 մլն
Net profit margin
-
-
-
-
Earnings per share
-1,23
-0,31
-0,62
-0,53
Interest and investment income
35,91 հզր
38,84 հզր
35,01 հզր
53,06 հզր
Interest expense
-
-
-
-
Net interest expenses
35,91 հզր
38,84 հզր
35,01 հզր
53,06 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps